Yahoo Finance | EN590 Commodities
EN590 Commodities GroupMarket Analysis 2026-06-11T10:20:35.000Z
Denali Therapeutics Inc. (NASDAQ:DNLI) is one of the10 best AI driven biotech stocks to invest in. On May 22, Denali Therapeutics Inc. (NASDAQ:DNLI) halted its joint work with Biogen Inc. (NASDAQ:BIIB), around the development of BIIB122 for idiopathic Parkinson’s disease. The decision came after topline results from the Phase 2b LUMA trial showed that the investigational small molecule inhibitor did not perform better than a placebo at slowing down symptoms, missing both primary and secondary clinical measures. Even though the molecule did not achieve its main clinical goals, lab tests showed it hit its expected biological targets. It achieved over 90% kinase inhibition of peripheral LRRK2, alongside an estimated 30% biomarker reduction in spinal fluid, while maintaining a safe profile. Lo
About EN590 Commodities Group
25+ years in mineral exploration and extraction. 15+ years of global commodity trading. Based in New York, USA serving 75+ countries.